Busch Andreas
Insider CIK 1775029 · ABSI Chief Innovation Officer, Director · CYCN Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABSI Absci Corp | P Buy | 2026-03-12 | 2026-03-16 | 100,000 | $2.29 | $229.0K | 421,446 | SEC↗ |
| ABSI Absci Corp | F Tax w/h | 2026-03-03 | 2026-03-04 | 1,257 | $2.80 | $3.5K | 321,446 | SEC↗ |
| ABSI Absci Corp | F Tax w/h | 2026-02-03 | 2026-02-04 | 1,469 | $2.99 | $4.4K | 322,703 | SEC↗ |
| ABSI Absci Corp | F Tax w/h | 2025-10-14 | 2025-10-14 | 3,092 | $3.68 | $11.4K | 324,172 | SEC↗ |
| ABSI Absci Corp | P Buy | 2025-07-28 | 2025-07-29 | 50,000 | $3.04 | $152.0K | 327,264 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2025-03-03 | 2025-03-04 | 93,700 | — | $0 | 93,700 | SEC↗ |
| ABSI Absci Corp | A Award | 2025-03-03 | 2025-03-04 | 23,700 | — | $0 | 277,264 | SEC↗ |
| ABSI Absci Corp | F Tax w/h | 2025-02-01 | 2025-02-04 | 1,469 | $3.71 | $5.4K | 253,564 | SEC↗ |
| ABSI Absci Corp | F Tax w/h | 2024-10-12 | 2024-10-16 | 3,092 | $4.07 | $12.6K | 255,033 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2024-02-01 | 2024-02-05 | 349,625 | — | $0 | 349,625 | SEC↗ |
| ABSI Absci Corp | A Award | 2024-02-01 | 2024-02-05 | 83,125 | — | $0 | 258,125 | SEC↗ |
| ABSI Absci Corp | A Award | 2023-10-12 | 2023-10-16 | 175,000 | — | $0 | 175,000 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2023-03-01 | 2023-03-03 | 550,000 | — | $0 | 550,000 | SEC↗ |
| ABSI | A Award deriv | 2022-10-03 | 2022-10-05 | 2,000,009 | — | $0 | 2,000,009 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2022-06-08 | 2022-06-10 | 4,783 | — | $0 | 4,783 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2022-03-17 | 2022-03-21 | 45,180 | — | $0 | 45,180 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2022-01-20 | 2022-01-24 | 135,000 | — | $0 | 135,000 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2021-12-09 | 2021-12-10 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | P Buy | 2020-11-09 | 2020-11-12 | 125,000 | $2.53 | $316.3K | 254,704 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2020-11-04 | 2020-11-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2019-11-22 | 2019-11-26 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | P Buy | 2019-11-15 | 2019-11-19 | 125,000 | $1.82 | $227.5K | 125,000 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2019-04-29 | 2019-05-01 | 300,000 | — | $0 | 300,000 | SEC↗ |